Inventor profile of:

Vered Domankevich

City:

Hod Hasharon

Country:

Israel

Published Applications:

30

Last publication date:

2026-01-01

Top Assignees for applications by Vered Domankevich

The entities that hold a legal rights for patent applications filed by inventor Domankevich Vered:

Recent patent applications by Domankevich Vered

Vered Domankevich from Hod Hasharon, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-01
US20260000912A1
Human necessities

Diffusing alpha-emitter radiation therapy for prostate cancer

#2 | 2025-11-06
US20250339572A1
Human necessities

Solution Loaded with Alpha-Emitter Radionuclides

#3 | 2025-07-17
US20250228986A1
Human necessities

Diffusing Alpha-Emitter Radiation Therapy for Lung Cancer

#4 | 2024-11-21
US20240382780A1
Human necessities

Diffusing alpha-emitter radiation therapy for melanoma

#5 | 2024-11-21
US20240382779A1
Human necessities

Diffusing alpha-emitter radiation therapy for colorectal cancer

#6 | 2024-11-14
US20240374922A1
Human necessities

Diffusing alpha-emitter radiation therapy for breast cancer

#7 | 2024-11-14
US20240374921A1
Human necessities

Diffusing alpha-emitter radiation therapy for glioblastoma

#8 | 2024-11-14
US20240374920A1
Human necessities

Diffusing alpha-emitter radiation therapy for pancreatic cancer

#9 | 2024-11-14
US20240374919A1
Human necessities

Activity levels for diffusing alpha-emitter radiation therapy

#10 | 2024-08-29
US20240285971A1
Human necessities

Intratumoral Alpha-Emitter Radiation in Combination with Vasculature Inhibitors

#11 | 2024-08-29
US20240285820A1
Human necessities

Intratumoral Alpha-Emitter Radiation in Combination with Immune Checkpoint Regulators

#12 | 2024-07-18
US20240238457A1
Human necessities

Gel Loaded with Alpha-Emitter Radionuclides

#13 | 2024-06-20
US20240198132A1
Human necessities

Diffusing alpha-emitter radiation therapy for prostate cancer

#14 | 2023-05-25
US20230158333A1
Human necessities

Diffusing alpha-emitter radiation therapy for prostate cancer

#15 | 2023-05-25
US20230158332A1
Human necessities

Diffusing alpha-emitter radiation therapy for squamous cell carcinoma

#16 | 2023-05-25
US20230158331A1
Human necessities

Diffusing alpha-emitter radiation therapy for colorectal cancer

#17 | 2023-05-25
US20230158330A1
Human necessities

Diffusing alpha-emitter radiation therapy for breast cancer

#18 | 2023-05-25
US20230158329A1
Human necessities

Diffusing alpha-emitter radiation therapy for glioblastoma

#19 | 2023-05-25
US20230158328A1
Human necessities

Activity levels for diffusing alpha-emitter radiation therapy

#20 | 2023-05-11
US20230143006A1
Human necessities

Diffusing alpha-emitter radiation therapy for melanoma

#21 | 2023-05-11
US20230142901A1
Human necessities

Diffusing alpha-emitter radiation therapy for pancreatic cancer

#22 | 2022-12-22
US20220401755A1
Human necessities

Diffusing alpha-emitter radiation therapy for squamous cell carcinoma

#23 | 2022-12-15
US20220395706A1
Human necessities

Diffusing alpha-emitter radiation therapy for breast and prostate cancer

#24 | 2022-12-15
US20220395704A1
Human necessities

Diffusing alpha-emitter radiation therapy for melanoma

#25 | 2022-12-15
US20220395703A1
Human necessities

Activity levels for diffusing alpha-emitter radiation therapy

#26 | 2022-12-15
US20220395702A1
Human necessities

Diffusing alpha-emitter radiation therapy for glioblastoma

#27 | 2022-12-15
US20220395701A1
Human necessities

Diffusing alpha-emitter radiation therapy for pancreatic cancer

#28 | 2022-12-15
US20220395700A1
Human necessities

Diffusing alpha-emitter radiation therapy for colon cancer

#29 | 2021-12-09
US20210379096A1
Human necessities

Intratumoral Alpha-Emitter Radiation and Activation of Cytoplasmatic Sensors for Intracellular Pathogen

#30 | 2011-06-21
US11755653
-

System, method, and computer program product for determining a price utilizing a pattern oriented rule implemented table

InventorID:

5261718 ⎘